Article
Combined silencing of VEGF-A and angiopoietin-2, a more effective way to inhibit the…
OncoTargets and Therapy · 2019 · Xu X, Yan Y, Xun Q, Shi J, Kong X, Wu J, Zhou H
Key facts
| Title | Combined silencing of VEGF-A and angiopoietin-2, a more effective way to inhibit the Ishikawa endometrial cancer cell line |
|---|---|
| First author | Xu X, Yan Y, Xun Q, Shi J, Kong X, Wu J, Zhou H |
| Journal | OncoTargets and Therapy |
| Published | Feb 14, 2019 |
| DOI | 10.2147/OTT.S194064 |
| Product codes mentioned | GIA |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1